methylprednisolone and Cancer of Nasopharynx

methylprednisolone has been researched along with Cancer of Nasopharynx in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's1 (10.00)29.6817
2010's7 (70.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Cai, J; Chen, M; Li, H; Li, Y; Mu, Y; Tang, Y; Xu, Y; Zhao, H; Zhuo, X1
Cai, Z; Hu, W; Huang, X; Li, Y; Rong, X; Tang, Y; Xu, Y; Zheng, D; Zuo, Z1
Cai, J; Chen, K; Huang, X; Li, H; Li, Y; Lin, J; Rong, X; Tang, Y; Xie, F; Xu, Y; Yan, M; Zhuo, X1
Bonny, M; Goethals, L; Kindts, I; Planckaert, N; Stellamans, K1
Han, J; Liu, J; Sun, H; Yang, D; Zhang, B1
Chen, J; Ou, Z; Tan, L; Wang, Y; Yu, Y; Zhao, Y; Zhou, X1
Jacobson, MC; Levin, W; McDowell, LJ1
Lam, TC; Leung, TW; Ng, SH; Tung, SY; Wong, FC1
Alpsoy, E; Demiral, AN; Simşir, V; Yerebakan, O1
Glaser, JS; Schatz, NJ; Zimmerman, CF1

Trials

1 trial(s) available for methylprednisolone and Cancer of Nasopharynx

ArticleYear
Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial.
    International journal of radiation oncology, biology, physics, 2018, 08-01, Volume: 101, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents, Immunological; Bevacizumab; Brain; Combined Modality Therapy; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Necrosis; Patient Safety; Radiation Injuries; Recurrence; Treatment Outcome

2018

Other Studies

9 other study(ies) available for methylprednisolone and Cancer of Nasopharynx

ArticleYear
A radiomics model for predicting the response to methylprednisolone in brain necrosis after radiotherapy for nasopharyngeal carcinoma.
    Radiation oncology (London, England), 2023, Mar-01, Volume: 18, Issue:1

    Topics: Brain; Humans; Methylprednisolone; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Necrosis; Radiation Injuries

2023
Comparison between high-dose and low-dose intravenous methylprednisolone therapy in patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2019, Volume: 137

    Topics: Adult; Aged; Brain; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Necrosis; Radiation Injuries; Retrospective Studies

2019
Case report of cold-weather-induced radiation recall dermatitis after chemoradiotherapy with cisplatin.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2014, Volume: 190, Issue:8

    Topics: Aged; Antineoplastic Agents; Butyrophenones; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Cold Temperature; Drug Therapy, Combination; Female; Humans; Methylprednisolone; Nasopharyngeal Neoplasms; Neoplasm Staging; Piperidines; Radiodermatitis

2014
Immunoglobulin G4-related disease in the skull base mimicking nasopharyngeal carcinoma.
    The Journal of craniofacial surgery, 2015, Volume: 26, Issue:2

    Topics: Aged; Autoimmune Diseases; Diagnosis, Differential; Fibrosis; Glucocorticoids; Humans; Immunoglobulin G; Lymphocytes; Male; Methylprednisolone; Nasopharyngeal Neoplasms; Plasma Cells; Skull Base

2015
Methylprednisolone use during radiotherapy extenuates hearing loss in patients with nasopharyngeal carcinoma.
    The Laryngoscope, 2016, Volume: 126, Issue:1

    Topics: Adult; Audiometry, Pure-Tone; Carcinoma; Evoked Potentials, Auditory, Brain Stem; Female; Hair Cells, Auditory, Outer; Hearing Loss, Sensorineural; Humans; Male; Methylprednisolone; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neuroprotective Agents; Otoacoustic Emissions, Spontaneous; Prospective Studies

2016
High-dose intravenous steroid regimen for radiation-induced hypoglossal nerve palsy.
    Head & neck, 2017, Volume: 39, Issue:2

    Topics: Adult; Carcinoma; Chemoradiotherapy; Deglutition; Deglutition Disorders; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Hypoglossal Nerve Diseases; Infusions, Intravenous; Male; Methylprednisolone; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retreatment; Speech Intelligibility; Treatment Outcome

2017
Clinical outcomes of 174 nasopharyngeal carcinoma patients with radiation-induced temporal lobe necrosis.
    International journal of radiation oncology, biology, physics, 2012, Jan-01, Volume: 82, Issue:1

    Topics: Age Factors; Analysis of Variance; Brachytherapy; Carcinoma; Female; Follow-Up Studies; Glucocorticoids; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Necrosis; Neuroprotective Agents; Prognosis; Retreatment; Risk; Salvage Therapy; Survival Rate; Temporal Lobe; Treatment Outcome

2012
Amifostine-induced toxic epidermal necrolysis during radiotherapy: a case report.
    Japanese journal of clinical oncology, 2002, Volume: 32, Issue:11

    Topics: Amifostine; Anti-Inflammatory Agents; Dose Fractionation, Radiation; Humans; Male; Methylprednisolone; Middle Aged; Nasopharyngeal Neoplasms; Radiation-Protective Agents; Stevens-Johnson Syndrome

2002
Magnetic resonance imaging of radiation optic neuropathy.
    American journal of ophthalmology, 1990, Oct-15, Volume: 110, Issue:4

    Topics: Adenoma; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Nasopharyngeal Neoplasms; Optic Nerve; Optic Nerve Diseases; Pituitary Neoplasms; Radiation Injuries; Sella Turcica; Skull Neoplasms

1990